Genitourinary Surgical Consultants

Denver, Colorado 80220

0 studies enrolling now · 17 studies all time

What they study most

Benign Prostatic Hypertrophy, Interstitial Cystitis, Lower Urinary Tract Symptoms (LUTS), Nocturia, Overactive Bladder, Stress Urinary Incontinence, Urinary Bladder, Overactive, Urinary Incontinence, Urinary Incontinence, Stress

Studies at this site

• Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence — Withdrawn before enrolling
• Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence — Withdrawn before enrolling
• Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence — Completed
• Bulking Agents for the Treatment of Stress Urinary Incontinence in Females — Completed
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence — Completed
• Solace Stress Urinary inContinence Control Efficacy and Safety Study — Completed
• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) — Stopped early
• OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder — Completed
• An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults — Completed
• Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
• Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients — Completed
• Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis — Stopped early
• A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) — Completed
• The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence — Completed
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence. — Completed
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) — Completed